Rethinking the Molecular Diagnostics for Methicillin-Resistant Staphylococcus aureus

Infect Control Hosp Epidemiol. 2018 Apr;39(4):495-496. doi: 10.1017/ice.2018.17. Epub 2018 Feb 21.

Authors

Claudia Stein¹, Jörg Tittelbach², Stefan Monecke³, Sebastian Weis¹, Oliwia Makarewicz¹, Ralf Ehricht³, Mathias Pletz¹

Affiliations

¹ 1Center for Infectious Disease and Infection Control,Jena University Hospital,Jena,Germany.
² 2Department of Dermatology,Jena University Hospital,Jena,Germany.
³ 3Abbott Rapid Diagnostics,Alere Technologies GmbH,Jena,Germany.

PMID: 29463331
DOI: 10.1017/ice.2018.17

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Infective Agents / therapeutic use
Foot Ulcer* / etiology
Foot Ulcer* / microbiology
Foot Ulcer* / therapy
Humans
Imines
Laboratory Proficiency Testing
Male
Methicillin-Resistant Staphylococcus aureus* / drug effects
Methicillin-Resistant Staphylococcus aureus* / genetics
Methicillin-Resistant Staphylococcus aureus* / isolation & purification
Middle Aged
Molecular Diagnostic Techniques / methods
Pyridines / therapeutic use*
Staphylococcal Infections* / diagnosis
Staphylococcal Infections* / drug therapy
Staphylococcal Infections* / etiology
Sterilization / methods*
Treatment Outcome
Venous Thrombosis / complications

Substances

Anti-Infective Agents
Imines
Pyridines
octenidine